News

Check the latest news from our invested white space companies.

FDA Grants Emergency Use Authorization for Visby Medical’s COVID-19 RT-PCR Test for Pooled Samples

San Jose, CA – September 13, 2021 – Visby Medical™ announced today that its instrument-free Reverse Transcription (RT)-Polymerase Chain Reac... Read More

CellMax Life’s Cancer Blood Test Designated FDA Breakthrough Device

Molecular diagnostics company CellMax Life’s FirstSight pre-cancer and cancer detection blood test has received the FDA’s Breakthrough Devic... Read More

RBC and ApplyBoard team up to support international students on their Canadian educational journey

New Proof of Financial Support solution leverages ApplyProof, ApplyBoard's document verification platform and the RBC International Student ... Read More

Startup Virsec Systems says it can eliminate the need for most cybersecurity tools

Having dwelt largely in the shadows for the past six years, cybersecurity startup Virsec Systems Inc. is now doing some flag-waving about it... Read More

CellMax Life gets FDA breakthrough device status for pre-cancer and cancer detection blood test

Molecular diagnostics company CellMax Life has secured breakthrough device designation from the US Food and Drug Administration (FDA) for it... Read More

ApplyBoard Ranked #8 on LinkedIn’s 2021 Top Startups List in Canada

ApplyBoard is thrilled to announce that we’ve ranked #8 on LinkedIn’s 2021 Top Startups List in Canada!... Read More

Virsec Strengthens Executive Team with Four Key Appointments

SAN JOSE, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Virsec, the only cybersecurity company to fully protect software at the workload while i... Read More

Visby Medical Appoints Industry Veteran Thomas Prescott as Chairman of the Board

SAN JOSE, Calif., Oct. 28, 2021 /PRNewswire/ -- Visby Medical™, a leading medical diagnostic company, today announced Thomas Prescott, forme... Read More

WCLC 2021 : Cellworks Clinical Trial Results Presented at IASLC 2021 World Conference on Lung Cancer

SOUTH SAN FRANCISCO, Calif., September 13, 2021 – Cellworks Group, Inc., a world leader in Personalized Medicine in the key therapeutic area... Read More

ASCO 2021 : Cellworks Singula™ Accurately Predicts Clinical Outcome from Treatments in Patients with NSCLC

SOUTH SAN FRANCISCO, Calif., June 4, 2021 – Cellworks Group, Inc., a world leader in Personalized Medicine in the key therapeutic areas of O... Read More

1